An Efficacy Study of Esomeprazole in Patients with Reflux Esophagitis Poorly Responsive to Lansoprazole

Trial Profile

An Efficacy Study of Esomeprazole in Patients with Reflux Esophagitis Poorly Responsive to Lansoprazole

Discontinued
Phase of Trial: Phase III

Latest Information Update: 26 Aug 2014

At a glance

  • Drugs Esomeprazole (Primary) ; Rabeprazole
  • Indications Reflux oesophagitis
  • Focus Therapeutic Use
  • Acronyms CHANGE-L
  • Most Recent Events

    • 06 Aug 2014 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan record.
    • 11 Mar 2014 Planned End Date changed from 31 Aug 2014 to 31 Jul 2014 as reported by University Hospital Medical Information Network - Japan record.
    • 25 Jan 2013 Planned end date (31 Aug 2014) added as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top